Open AccessOptimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective
Author(s) -
Emmanuelle Papot,
Richard Kaplan,
Marco Vitória,
Mark N. Polizzotto
Publication year - 2021
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000003108
Subject(s) - dolutegravir , regimen , efavirenz , medicine , tolerability , lamivudine , context (archaeology) , abacavir , second line , antiretroviral therapy , life expectancy , intensive care medicine , viral load , adverse effect , human immunodeficiency virus (hiv) , family medicine , immunology , first line , population , environmental health , virus , hepatitis b virus , paleontology , biology